ONC Short Volume

BeOne Medicines AG (ONC) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $37.30B, listed on NASDAQ, employing roughly 12,000 people, carrying a beta of 0.52 to the broader market. BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. Led by John V. Oyler, public since 2016-02-03.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date

2026-10-14

Short Volume

66.6K

Total Volume

94.1K

Short %

70.75%

30-Day Avg Short %

64.59%

Showing 30 days of FINRA short volume data for BeOne Medicines AG.

Learn how short volume is reported and how to read the data →

Frequently asked ONC short volume questions

What is the daily ONC short volume?

As of Oct 14, 2026, BeOne Medicines AG (ONC) short volume is 66.6K shares against 94.1K total reported volume, or 70.75% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.

How is ONC short volume reported?

FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.

What does ONC short volume tell options traders?

Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.